24 insiders bought €426.8M of shares over the last 90 days, the latest by 국민연금공단, filed 29 Sept 2026.
Who traded when
BuySale+29 other insiders
Since the insiders bought
- +61.1%Entry ₩264,500 · Close at T+365 ₩426,000
- -3.3%Entry ₩289,000 · Close at T+365 ₩279,500
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Hanmi Pharm. Co., Ltd. Buy (bullish), based on 11 analysts. Average price target: ₩635,455.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- 1,286,142 sharesShareKRXDART:20260929000085Canonical exit: 28 Dec 2026 (T+90)
- Other0DART
- Other0DART
- Other0DART
- 67 sharesShareKRXDART:20260811000697Canonical exit: 9 Nov 2026 (T+90)
- 16 sharesShareKRXDART:20260811000685Canonical exit: 9 Nov 2026 (T+90)
- 17 sharesShareKRXDART:20260811000677Canonical exit: 9 Nov 2026 (T+90)
- 34 sharesShareKRXDART:20260811000656Canonical exit: 9 Nov 2026 (T+90)
- 60 sharesShareKRXDART:20260811000653Canonical exit: 9 Nov 2026 (T+90)
- 16 sharesShareKRXDART:20260811000635Canonical exit: 9 Nov 2026 (T+90)
- 6 sharesShareKRXDART:20260811000631Canonical exit: 9 Nov 2026 (T+90)
- 69 sharesShareKRXDART:20260811000617Canonical exit: 9 Nov 2026 (T+90)
- 36 sharesShareKRXDART:20260811000607Canonical exit: 9 Nov 2026 (T+90)
- 102 sharesShareKRXDART:20260811000698Canonical exit: 9 Nov 2026 (T+90)
- 336 sharesShareKRXDART:20260811000687Canonical exit: 9 Nov 2026 (T+90)
- 57 sharesShareKRXDART:20260811000667Canonical exit: 9 Nov 2026 (T+90)
- 81 sharesShareKRXDART:20260811000608Canonical exit: 9 Nov 2026 (T+90)
- 21 sharesShareKRXDART:20260811000647Canonical exit: 9 Nov 2026 (T+90)
- 86 sharesShareKRXDART:20260811000675Canonical exit: 9 Nov 2026 (T+90)
- 528 sharesShareKRXDART:20260811000692Canonical exit: 9 Nov 2026 (T+90)
- 75 sharesShareKRXDART:20260811000668Canonical exit: 9 Nov 2026 (T+90)
- 31 sharesShareKRXDART:20260811000689Canonical exit: 9 Nov 2026 (T+90)
- 54 sharesShareKRXDART:20260811000683Canonical exit: 9 Nov 2026 (T+90)
25 of 149 declarations
About Hanmi Pharm. Co., Ltd.
Between January 5 and January 29, 2026, 29 filers at Hanmi Pharm. Co., Ltd. (한미약품) filed within the same window, mostly purchases. Across the whole record there are 95 purchases against 26 sales, so purchases are 79% of open-market trades, with 22 filings of another kind, among 143 filings in total. No open-market trade carries an amount.
국민연금공단, a holder of more than 10%, files 53 filings (18 purchases, 21 sales). 한미사이언스, a large holder, files 7 (3 purchases, 3 sales). 최창주, 두명국 and 김나영 (사내이사, vice president) each file 4 filings, all of them purchases. They are among the 43 filers in the record.
Read moreShow less
This South Korean health care company has a market capitalisation of KRW 4,815.5 billion, and insiders hold 49.6% of it. Annual volume goes from 13 filings in 2025 to 66 in 2026; 69 filings fall in the last twelve months, 56 purchases and 9 sales. Publication is slow: a median of 19 days. The 10 purchases have a 90-day follow-up: median -13%, with 10% of cases positive. That is a recorded past, never a forecast.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
